Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
Condition(s):Effect of DrugLast Updated:February 21, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Effect of DrugLast Updated:February 21, 2023Recruiting
Condition(s):Solid TumorLast Updated:November 29, 2023Recruiting
Condition(s):Myelodysplastic SyndromesLast Updated:September 1, 2023Not yet recruiting
Condition(s):Autism; Treatment Adherence; Retinoic Acid; Dup15Q SyndromeLast Updated:March 16, 2022Recruiting
Condition(s):Acanthosis Nigricans; HyperpigmentationLast Updated:January 19, 2024Not yet recruiting
Condition(s):Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:March 13, 2024Recruiting
Condition(s):Breast CancerLast Updated:October 24, 2023Not yet recruiting
Condition(s):Colorectal CancerLast Updated:January 19, 2024Recruiting
Condition(s):Multiple Myeloma in Relapse; Multiple Myeloma, RefractoryLast Updated:December 11, 2023Recruiting
Condition(s):Glioma; IDH Mutation; Astrocytoma; OligodendrogliomaLast Updated:November 30, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.